{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Akron%20Formulations%20India%20Private%20Limited","name":"Akron Formulations India Private Limited","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-04T06:12:30.913Z"},"count":1,"matches":[{"id":"fa8d1b2e58d65945","posted_date":"2024-12-24","letter_issue_date":"2024-12-17","company_name":"Akron Formulations India Private Limited","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceutical/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/fa8d1b2e58d65945"}]}